RDCRN
RDCRN
RDCRN (pronounced: R-D-C-R-N), an acronym for Rare Diseases Clinical Research Network, is a collaborative initiative dedicated to advancing medical research on rare diseases.
Etymology
The term RDCRN is an abbreviation derived from the first letters of the words in the phrase "Rare Diseases Clinical Research Network". The term "rare diseases" refers to conditions that affect a small percentage of the population. "Clinical research" is a branch of healthcare science that determines the safety and effectiveness of medications, devices, diagnostic products, and treatment regimens intended for human use. A "network" in this context refers to a group of interconnected people or organizations.
Related Terms
- Clinical Research: A branch of healthcare science that determines the safety and effectiveness of medications, devices, diagnostic products, and treatment regimens intended for human use.
- Rare Diseases: A category of diseases that are not common among the population. In the United States, a disease is considered rare if it affects fewer than 200,000 people at any given time.
- Research Network: A group of individuals or organizations working together to conduct research on a particular topic or field.
- National Institutes of Health (NIH): The primary agency of the United States government responsible for biomedical and public health research. The RDCRN is funded and managed by the NIH's Office of Rare Diseases Research (ORDR) and the National Center for Advancing Translational Sciences (NCATS).
See Also
External links
- Medical encyclopedia article on RDCRN
- Wikipedia's article - RDCRN
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski